Advances in the genetics of familial renal cancer

Oncologist

Volumn 15, Issue 6, 2010, Pages 532-538

  Morrison, Patrick J ^a   Donnelly, Deirdre E ^a   Atkinson, A Brew ^b   Maxwell, Alexander P ^c  

^a ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

^b ROYAL VICTORIA HOSPITAL   (United Kingdom)

^c BELFAST CITY HOSPITAL   (United Kingdom)

Author keywords

Clear cell; Familial; MET; Papillary; Renal cancer

Indexed keywords

ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BIRT HOGG DUBE SYNDROME; CANCER DIAGNOSIS; CANCER GENETICS; CANCER SCREENING; CARCINOGENESIS; CHROMOSOME 3; CHROMOSOME TRANSLOCATION; CLEAR CELL RENAL CELL CANCER; CLINICAL FEATURE; FAMILIAL CANCER; FAMILIAL PARAGANGLIOMA SYNDROME; FAMILIAL RENAL HAMARTOMA; HAMARTOMA; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HEREDITARY PAPILLARY RENAL CANCER; HISTOPATHOLOGY; HUMAN; HYPERPARATHYROIDISM; JAW TUMOR; JAW TUMOR SYNDROME; KIDNEY CARCINOMA; LEIOMYOMA; ONCOCYTOMA; PARAGANGLIOMA; PREVALENCE; PRIORITY JOURNAL; THYROID PAPILLARY CARCINOMA; TUBEROUS SCLEROSIS; VON HIPPEL LINDAU DISEASE; GENETICS; KIDNEY NEOPLASMS; PATHOLOGY;

HUMANS; KIDNEY NEOPLASMS; NEOPLASTIC SYNDROMES, HEREDITARY;

EID: 77954978435     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2010-0023     Document Type: Article

References (34)

1. American Cancer Society. What Are the Key Statistics for Kidney Cancer? Available at http://www.cancer.org/docroot/cri/content/cri_2_4_1x_what_are_the_key_statistics_for_kidney_cancer_22.asp?sitearea_&level, accessed January 20, 2010.
2. Lonser RR, Glenn GM, Walther M et al. von Hippel-Lindau disease. Lancet 2003;361;2059-2067.
3. Maher ER, Yates JR, Harries R et al. Clinical features and natural history of von Hippel-Lindau disease. Q J Med 1990;77:1151-1163.
4. Wiesener MS, Seyfarth M, Warnecke C et al. Paraneoplastic erythrocytosis associated with an inactivating point mutation of the von Hippel-Lindau gene in a renal cell carcinoma. Blood 2002;99:3562-3565.
5. Choyke PL, Glenn GM, Walther MM et al. The natural history of renal lesions in von Hippel-Lindau disease: A serial CT study in 28 patients. AJR Am J Roentgenol 1992;159:1229-1234.
6. Nickerson ML, Warren MB, Toro JR et al. Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndrome. Cancer Cell 2002;2:157-164.
7. Toro JR, Wei MH, Glenn GM et al. BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dubé syndrome: A new series of 50 families and a review of published reports. J Med Genet 2008;45:321-331.
8. Pavlovich CP, Grubb RL 3rd, Hurley K et al. Evaluation and management of renal tumors in the Birt-Hogg-Dubé syndrome. J Urol 2005;173:1482-1486.
9. Schmidt LS, Nickerson ML, Warren MB et al. Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dubé syndrome. Am J Hum Genet 2005;76:1023-1033.
10. Gunji Y, Akiyoshi T, Sato T et al. Mutations of the Birt-Hogg-Dubé gene in patients with multiple lung cysts and recurrent pneumothorax. J Med Genet 2007;44:588-593.
11. Menko FH, van Steensel MA, Giraud S et al. Birt-Hogg-Dubé syndrome: Diagnosis and management. Lancet Oncol 2009;10:1199-1206.
12. Alam NA, Rowan AJ, Wortham N et al. Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency. Hum Mol Genet 2003;12:1241-1252.
13. Wei MH, Toure O, Pithukpakorn M et al. Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer. J Med Genet 2006;43:18-27.
14. Alrashdi I, Levine S, Paterson J et al. Hereditary leiomyomatosis and renal cell carcinoma: Very early diagnosis of renal cancer in a paediatric patient. Fam Cancer 2010;9:239-244.
15. Schmidt L, Junker K, Weirich G et al. Two North American families with hereditary papillary renal carcinoma and identical novel mutations in the MET proto-oncogene. Cancer Res 1998;58:1719-1722.
16. Choyke PL, Walther MM, Glenn GM et al. Imaging features of hereditary papillary renal cancers. J Comput Assist Tomogr 1997;21:737-741.
17. Schmidt L, Li F, Brown RS et al. Mechanism of tumorigenesis of renal carcinomas associated with the constitutional chromosome 3;8 translocation. Cancer J Sci Am 1995;1:191-195.
18. Woodward ER, Ricketts C, Killick P et al. Familial non-VHL clear cell (conventional) renal cell carcinoma: Clinical features, segregation analysis, and mutation analysis of FLCN. Clin Cancer Res 2008;14:5925-5930.
19. Newmann HP, Pawlu C, Peczkowska M et al. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 2004;292;943-951.
20. Cook JA, Oliver K, Mueller RF et al. A cross sectional study of renal involvement in tuberous sclerosis. J Med Genet 1996;33:480-484.
21. Morrison PJ. Tuberous sclerosis: Epidemiology, genetics and progress towards treatment. Neuroepidemiology 2009;33:342-343.
22. Robertson FM, Cendron M, Klauber GT et al. Renal cell carcinoma in association with tuberous sclerosis in children. J Pediatr Surg 1996;31:729-730.
23. Srirangalingam U, Walker L, Khoo B et al. Clinical manifestations of familial paraganglioma and phaeochromoctyomas in succinate dehydrogenase B (SDH-B) gene mutation carriers. Clin Endocrinol (Oxf) 2008;69: 587-596.
24. Ricketts CJ, Forman JR, Rattenbury E et al. Tumour risks and genotypephenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHD. Hum Mutat 2010;31:41-51.
25. Henderson A, Douglas F, Perros P et al. SDHB-associated renal oncocytoma suggests a broadening of the renal phenotype in hereditary paragangliomatosis. Fam Cancer 2009;8:257-260.
26. Morrison PJ, Atkinson AB. Genetic aspects of familial thyroid cancer. The Oncologist 2009;14:571-577.
27. Malchoff CD, Sarfarazi M, Tendler B et al. Papillary thyroid carcinoma associated with papillary renal neoplasia: Genetic linkage analysis of a distinct heritable tumor syndrome. J Clin Endocr Metab 2000;85:1758-1764.
28. Carpten JD, Robbins CM, Villablanca A et al. HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet 2002;32:676-680.
29. Hemminki K, Li X. Familial renal cell cancer appears to have a recessive component. J Med Genet 2004;41:e58.
30. Teh BT, Blennow E, Giraud S et al. Bilateral multiple renal oncocytomas and cysts associated with a constitutional translocation (8;9)(q24.1;q34.3) and a rare constitutional VHL missense substitution. Genes Chromosomes Cancer 1998;21:260-264.
31. Vasen HF, Möslein G, Alonso A et al. Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis colon cancer). J Med Genet 2007;44:353-362.
32. Devlin LA, Graham CA, Price JH et al. Germline MSH6 mutations are more prevalent in endometrial cancer patient cohorts than hereditary non polyposis colorectal cancer cohorts. Ulster Med J 2008;77:25-30.
33. Israel GM, Bosniak MA. An update of the Bosniak renal cyst classification system. Urology 2005;66:484-488.
34. Rini BI, Campbell SC, Escudier B. Renal cell carcinoma. Lancet 2009;373: 1119-1132.